Shares of BridgeBio Pharma Inc. are expected to begin trading on the Nasdaq Global Select Market today (June 27, 2019), under the ticker symbol "BBIO".
The Company has priced its initial public offering of 20.50 million shares of its common stock at $17.00 per share, above the previously announced range of $14.00 to $16.00.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com